228 related articles for article (PubMed ID: 21875799)
21. Aib residues in peptaibiotics and synthetic sequences: analysis of nonhelical conformations.
Aravinda S; Shamala N; Balaram P
Chem Biodivers; 2008 Jul; 5(7):1238-62. PubMed ID: 18649312
[TBL] [Abstract][Full Text] [Related]
22. Novel cell-penetrating peptides based on α-aminoxy acids.
Ma Y; Yang D; Ma Y; Zhang YH
Chembiochem; 2012 Jan; 13(1):73-9. PubMed ID: 22162305
[TBL] [Abstract][Full Text] [Related]
23. Systematic screening of the cellular uptake of designed alpha-helix peptides.
Usui K; Kikuchi T; Mie M; Kobatake E; Mihara H
Bioorg Med Chem; 2013 May; 21(9):2560-7. PubMed ID: 23498920
[TBL] [Abstract][Full Text] [Related]
24. Nonhemolytic Cell-Penetrating Peptides: Site Specific Introduction of Glutamine and Lysine Residues into the α-Helical Peptide Causes Deletion of Its Direct Membrane Disrupting Ability but Retention of Its Cell Penetrating Ability.
Kim S; Hyun S; Lee Y; Lee Y; Yu J
Biomacromolecules; 2016 Sep; 17(9):3007-15. PubMed ID: 27442521
[TBL] [Abstract][Full Text] [Related]
25. The role of tryptophans on the cellular uptake and membrane interaction of arginine-rich cell penetrating peptides.
Jobin ML; Blanchet M; Henry S; Chaignepain S; Manigand C; Castano S; Lecomte S; Burlina F; Sagan S; Alves ID
Biochim Biophys Acta; 2015 Feb; 1848(2):593-602. PubMed ID: 25445669
[TBL] [Abstract][Full Text] [Related]
26. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues.
Song YM; Park Y; Lim SS; Yang ST; Woo ER; Park IS; Lee JS; Kim JI; Hahm KS; Kim Y; Shin SY
Biochemistry; 2005 Sep; 44(36):12094-106. PubMed ID: 16142907
[TBL] [Abstract][Full Text] [Related]
27. Oral biodrug delivery using cell-penetrating peptide.
Khafagy el-S; Morishita M
Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
[TBL] [Abstract][Full Text] [Related]
28. Effect of alpha,alpha-dialkyl amino acids on the protease resistance of peptides.
Yamaguchi H; Kodama H; Osada S; Kato F; Jelokhani-Niaraki M; Kondo M
Biosci Biotechnol Biochem; 2003 Oct; 67(10):2269-72. PubMed ID: 14586119
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationship study of Aib-containing amphipathic helical peptide-cyclic RGD conjugates as carriers for siRNA delivery.
Wada SI; Takesada A; Nagamura Y; Sogabe E; Ohki R; Hayashi J; Urata H
Bioorg Med Chem Lett; 2017 Dec; 27(24):5378-5381. PubMed ID: 29157863
[TBL] [Abstract][Full Text] [Related]
30. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
[TBL] [Abstract][Full Text] [Related]
31. Structural requirements for cellular uptake of alpha-helical amphipathic peptides.
Scheller A; Oehlke J; Wiesner B; Dathe M; Krause E; Beyermann M; Melzig M; Bienert M
J Pept Sci; 1999 Apr; 5(4):185-94. PubMed ID: 10323198
[TBL] [Abstract][Full Text] [Related]
32. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
[TBL] [Abstract][Full Text] [Related]
33. Chemoenzymatic synthesis of polypeptides containing the unnatural amino acid 2-aminoisobutyric acid.
Tsuchiya K; Numata K
Chem Commun (Camb); 2017 Jun; 53(53):7318-7321. PubMed ID: 28485427
[TBL] [Abstract][Full Text] [Related]
34. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
Crombez L; Morris MC; Heitz F; Divita G
Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
[TBL] [Abstract][Full Text] [Related]
35. Distinct uptake routes of cell-penetrating peptide conjugates.
Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
[TBL] [Abstract][Full Text] [Related]
36. Crystal-state conformation of Calpha,alpha-dialkylated peptides containing chiral beta-homo-residues.
Romanelli A; Garella I; Menchise V; Iacovino R; Saviano M; Montesarchio D; Didierjean C; Di Lello P; Rossi F; Benedetti E
J Pept Sci; 2001 Jan; 7(1):15-26. PubMed ID: 11245201
[TBL] [Abstract][Full Text] [Related]
37. When cationic cell-penetrating peptides meet hydrocarbons to enhance in-cell cargo delivery.
Di Pisa M; Chassaing G; Swiecicki JM
J Pept Sci; 2015 May; 21(5):356-69. PubMed ID: 25787823
[TBL] [Abstract][Full Text] [Related]
38. Design of cyclic RGD-conjugated Aib-containing amphipathic helical peptides for targeted delivery of small interfering RNA.
Wada SI; Iwata M; Ozaki Y; Ozaki T; Hayashi J; Urata H
Bioorg Med Chem; 2016 Sep; 24(18):4478-4485. PubMed ID: 27480031
[TBL] [Abstract][Full Text] [Related]
39. Conformational manifold of alpha-aminoisobutyric acid (Aib) containing alanine-based tripeptides in aqueous solution explored by vibrational spectroscopy, electronic circular dichroism spectroscopy, and molecular dynamics simulations.
Schweitzer-Stenner R; Gonzales W; Bourne GT; Feng JA; Marshall GR
J Am Chem Soc; 2007 Oct; 129(43):13095-109. PubMed ID: 17918837
[TBL] [Abstract][Full Text] [Related]
40. Incorporation of a potentially helix breaking D-Phe-Pro sequence into the center of a right handed 16 residue peptide helix.
Gurunath R; Balaram P
Biochem Biophys Res Commun; 1994 Jul; 202(1):241-5. PubMed ID: 8037717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
